Paradigm Shift in COPD Treatment With New Wave Therapies : c

Experts express optimism regarding the COPD pipeline, indicating a strong probability of licensure for Dupixent and Ensifentrine.

Related Keywords

Sanofi Regeneron Dupixent , Verona Ensifentrine , Sanofi Regeneron , Drug Administration , Regeneron Bridges , Biologics License Application , Key Opinion Leaders ,